|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
2
The Importance of Suppressor Cells in Tumor Progression
3
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
4
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
5
